| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 163,45 | 165,05 | 09:56 | |
| 163,45 | 165,05 | 09:56 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 167,45 | 1.200 | |||
| 167,40 | 4 | |||
| 167,05 | 120 | |||
| 166,95 | 300 | |||
| 166,55 | 2 | |||
| 166,45 | 2 | |||
| 166,30 | 300 | |||
| 166,20 | 61 | |||
| 165,60 | 80 | |||
| 165,55 | 109 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/idp.htm [/URL] | ||||
| 80 | 162,80 | |||
| 66 | 162,00 | |||
| 300 | 161,80 | |||
| 4 | 161,70 | |||
| 62 | 161,35 | |||
| 120 | 161,05 | |||
| 1.200 | 160,65 | |||
| 939 | 159,70 | |||
| 120 | 158,65 | |||
| 1.200 | 158,10 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 4.091 | 0,532 | 2.178 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 30.03.2026 | 17:35:55 | 164,10 | 10 |
| 30.03.2026 | 17:28:38 | 163,75 | 20 |
| 30.03.2026 | 13:19:32 | 159,50 | 7 |
| 30.03.2026 | 11:42:06 | 158,45 | 4 |
| 30.03.2026 | 11:42:05 | 158,65 | 21 |
| 30.03.2026 | 11:42:05 | 158,70 | 60 |
| Tagesumsatz Xetra | - | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | BofA reiterates Neutral on Biogen stock on portfolio updates | 2 | Investing.com | ||
| Mo | BofA bestätigt "Neutral"-Rating für Biogen nach Portfolio-Updates | 3 | Investing.com Deutsch | ||
| Mo | United rises on IPF data; Biogen scores positive lupus data and an approval | 3 | BioPharma Dive | ||
| BIOGEN Aktie jetzt für 0€ handeln | |||||
| Mo | Biogen Stock Pops After FDA Approves New High-Dose Spinraza For Spinal Muscular Atrophy | 4 | Benzinga.com | ||
| Mo | Biogen receives FDA approval for high-dose Spinraza regimen | 6 | Seeking Alpha |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 08:42 | Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal | AFX News | FOSTER CITY (dpa-AFX) - Galapagos (GLPG, GLPG.AS) has entered into a binding agreement with Gilead Sciences (GILD) in connection with Gilead's agreement to acquire all of the outstanding equity... ► Artikel lesen | |
| 09:18 | Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program | PR Newswire | GOTHENBURG, Sweden, March 31, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare... ► Artikel lesen | |
| 08:57 | ExoPTEN Therapie: In nur 10 Wochen von der Querschnittlähmung zurück zur Mobilität! | bullVestor | ||
| 08:50 | Genflow Biosciences PLC Announces Total Voting Rights | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 31, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") announces that the total issued share capital of the Company as at 31 March... ► Artikel lesen | |
| 09:00 | Genovis AB: Genovis and Plasmidsaurus Introduce SEQguard Dino Preserve - Enabling Ambient-Temperature RNA Shipping for Next-Generation Sequencing | GlobeNewswire (Europe) | Genovis AB today announces the commercial launch of SEQguard Dino Preserve, an RNA preservation product tested and optimized for Plasmidsaurus, a leading Sequencing as a Service company. The product... ► Artikel lesen |